{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:56:53Z","timestamp":1781650613447,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Fraunhofer-Institut f\u00fcr Zelltherapie und Immunologie IZI"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hemoadsorption with polystyrene-divinylbenzene (PS-DVB)-based adsorbents is explored as an adjunctive extracorporeal therapy in selected critically ill patients with dysregulated systemic inflammation. However, such therapy must not interfere with standard treatments, including antimicrobial therapy and hemodynamic stabilization with vasoactive drugs. As catecholamines are rarely quantified analytically in clinical practice, there are currently no studies reporting actual plasma levels during hemoadsorption. This in vitro study evaluated whether hemoadsorption with PS-DVB-based adsorbents alters plasma concentrations of epinephrine, norepinephrine, and dobutamine. Miniaturized PS-DVB adsorbers were used in 300-minute experiments; serial plasma samples were quantified, and apparent plasma clearance was derived from concentration-time data. Epinephrine and norepinephrine concentrations remained essentially unchanged over 300\u00a0min, with very low apparent plasma clearance (&lt;\u20095 mL\/min), indicating no meaningful removal under the tested conditions. By contrast, dobutamine demonstrated consistent, measurable clearance (approximately 5\u201315 mL\/min), indicating non-negligible adsorption. Under these in vitro conditions, PS-DVB hemoadsorption did not materially remove epinephrine or norepinephrine but produced measurable removal of dobutamine. These findings are compatible with observational reports of reduced overall vasopressor requirements during hemoadsorption, while highlighting the potential for dobutamine underexposure. Future clinical studies should directly measure therapeutic plasma levels \u2013 particularly for dobutamine \u2013 during PS-DVB hemoadsorption and assess whether dosing adjustments are required to maintain intended inotropic effects without compromising safety.<\/jats:p>","DOI":"10.1038\/s41598-026-49101-1","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T17:09:00Z","timestamp":1776704940000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of hemoadsorption on plasma catecholamine levels: an in vitro study"],"prefix":"10.1038","volume":"16","author":[{"given":"Andreas","family":"K\u00f6rtge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Klinkmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Kamper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhold","family":"Wasserkort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Mitzner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"49101_CR1","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s13054-022-04009-w","volume":"26","author":"C Ronco","year":"2022","unstructured":"Ronco, C. & Bellomo, R. Hemoperfusion: technical aspects and state of the art. Crit. Care. 26, 135. https:\/\/doi.org\/10.1186\/s13054-022-04009-w (2022).","journal-title":"Crit. Care"},{"key":"49101_CR2","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1007\/s00134-022-06810-1","volume":"48","author":"Z Ricci","year":"2022","unstructured":"Ricci, Z. et al. Hemoperfusion in the intensive care unit. Intensive Care Med. 48, 1397\u20131408. https:\/\/doi.org\/10.1007\/s00134-022-06810-1 (2022).","journal-title":"Intensive Care Med."},{"key":"49101_CR3","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2478\/jccm-2020-0036","volume":"6","author":"J Kovacs","year":"2020","unstructured":"Kovacs, J. Hemoadsorption in critical care - it is a useful or a harmful technique? Journal of critical care medicine (Universitatea de Medicina si Farmacie din. Targu-Mures) 6, 207\u2013209. https:\/\/doi.org\/10.2478\/jccm-2020-0036 (2020).","journal-title":"Targu-Mures)"},{"key":"49101_CR4","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3390\/biomedicines8120539","volume":"8","author":"C Rugg","year":"2020","unstructured":"Rugg, C. et al. Hemoadsorption with CytoSorb in septic shock reduces catecholamine requirements and in-hospital mortality: A single-center retrospective \u2018Genetic\u2019 matched analysis. Biomedicines 8, 539. https:\/\/doi.org\/10.3390\/biomedicines8120539 (2020).","journal-title":"Biomedicines"},{"key":"49101_CR5","doi-asserted-by":"publisher","first-page":"7199","DOI":"10.3390\/jcm12237199","volume":"12","author":"S Mitzner","year":"2023","unstructured":"Mitzner, S. et al. Adjunctive hemoadsorption therapy with CytoSorb in patients with septic\/vasoplegic shock: A best practice consensus statement. J. Clin. Med. 12, 7199. https:\/\/doi.org\/10.3390\/jcm12237199 (2023).","journal-title":"J. Clin. Med."},{"key":"49101_CR6","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s40635-025-00740-0","volume":"13","author":"NJB Waalders","year":"2025","unstructured":"Waalders, N. J. B., Kox, M. & Pickkers, P. Haemoadsorption to remove inflammatory mediators in sepsis: past, present, and future. Intensive Care Med. Exp. 13, 38. https:\/\/doi.org\/10.1186\/s40635-025-00740-0 (2025).","journal-title":"Intensive Care Med. Experimental"},{"key":"49101_CR7","doi-asserted-by":"publisher","first-page":"e0246299","DOI":"10.1371\/journal.pone.0246299","volume":"16","author":"K Boss","year":"2021","unstructured":"Boss, K. et al. Extracorporeal cytokine adsorption: Significant reduction of catecholamine requirement in patients with AKI and septic shock after cardiac surgery. PLoS One. 16, e0246299. https:\/\/doi.org\/10.1371\/journal.pone.0246299 (2021).","journal-title":"PLoS ONE"},{"key":"49101_CR8","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.3390\/jcm14072285","volume":"14","author":"D Steindl","year":"2025","unstructured":"Steindl, D. et al. Hemoadsorption in the management of septic shock: A systematic review and meta-analysis. J. Clin. Med. 14, 2285. https:\/\/doi.org\/10.3390\/jcm14072285 (2025).","journal-title":"J. Clin. Med."},{"key":"49101_CR9","doi-asserted-by":"publisher","first-page":"10493","DOI":"10.1038\/s41598-021-89965-z","volume":"11","author":"AG Schneider","year":"2021","unstructured":"Schneider, A. G. et al. Pharmacokinetics of anti-infective agents during CytoSorb hemoadsorption. Sci. Rep. 11, 10493. https:\/\/doi.org\/10.1038\/s41598-021-89965-z (2021).","journal-title":"Sci. Rep."},{"key":"49101_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1177\/0391398818812601","volume":"42","author":"C K\u00f6nig","year":"2019","unstructured":"K\u00f6nig, C. et al. In vitro removal of anti-infective agents by a novel cytokine adsorbent system. Int. J. Artif. Organs. 42, 57\u201364. https:\/\/doi.org\/10.1177\/0391398818812601 (2019).","journal-title":"Int. J. Artif. Organs"},{"key":"49101_CR11","doi-asserted-by":"publisher","unstructured":"Berlot, G. et al. The Effects of hemoadsorption on the kinetics of antibacterial and antifungal agents. Antibiot. (Basel). 11. https:\/\/doi.org\/10.3390\/antibiotics11020180 (2022).","DOI":"10.3390\/antibiotics11020180"},{"key":"49101_CR12","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.1097\/JTCCM-D-24-00011","volume":"6","author":"T Furukawa","year":"2024","unstructured":"Furukawa, T., Lankadeva, Y. & Bellomo, R. The impact of hemoadsorption on antimicrobials. J. Transl Crit. Care Med. 6, e24. https:\/\/doi.org\/10.1097\/JTCCM-D-24-00011 (2024).","journal-title":"J. Transl Crit. Care Med."},{"key":"49101_CR13","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1007\/s00134-021-06487-y","volume":"47","author":"U Liebchen","year":"2021","unstructured":"Liebchen, U. et al. No clinically relevant removal of meropenem by cytokine adsorber CytoSorb\u00ae in critically ill patients with sepsis or septic shock. Intensive Care Med. 47, 1332\u20131333. https:\/\/doi.org\/10.1007\/s00134-021-06487-y (2021).","journal-title":"Intensive Care Med."},{"key":"49101_CR14","doi-asserted-by":"publisher","unstructured":"Lemagnen, I. et al. Drug removal by hemoadsorption. Blood Purif. 1\u201313. https:\/\/doi.org\/10.1159\/000545804 (2025).","DOI":"10.1159\/000545804"},{"key":"49101_CR15","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13054-017-1662-9","volume":"21","author":"K Kogelmann","year":"2017","unstructured":"Kogelmann, K. et al. Hemoadsorption by CytoSorb in septic patients: a case series. Crit. Care. 21, 74. https:\/\/doi.org\/10.1186\/s13054-017-1662-9 (2017).","journal-title":"Crit. Care"},{"key":"49101_CR16","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jcrc.2018.11.003","volume":"49","author":"F Hawchar","year":"2019","unstructured":"Hawchar, F. et al. Extracorporeal cytokine adsorption in septic shock: A proof of concept randomized, controlled pilot study. J. Crit. Care. 49, 172\u2013178. https:\/\/doi.org\/10.1016\/j.jcrc.2018.11.003 (2019).","journal-title":"J. Crit. Care"},{"key":"49101_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5492\/wjccm.v9.i1.1","volume":"9","author":"Y Mehta","year":"2020","unstructured":"Mehta, Y. et al. Experience with hemoadsorption (CytoSorb\u00ae) in the management of septic shock patients. World J. Crit. care Med. 9, 1\u201312. https:\/\/doi.org\/10.5492\/wjccm.v9.i1.1 (2020).","journal-title":"World J. Crit. care Med."},{"key":"49101_CR18","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.burns.2024.02.028","volume":"50","author":"F Mariano","year":"2024","unstructured":"Mariano, F. et al. CytoSorb\u00ae in burn patients with septic shock and Acute Kidney Injury on Continuous Kidney Replacement Therapy is associated with improved clinical outcome and survival. Burns: J. Int. Soc. Burn Injuries. 50, 1213\u20131222. https:\/\/doi.org\/10.1016\/j.burns.2024.02.028 (2024).","journal-title":"Burns: J. Int. Soc. Burn Injuries"},{"key":"49101_CR19","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1055\/s-0040-1708479","volume":"69","author":"A Akil","year":"2021","unstructured":"Akil, A. et al. Combined use of CytoSorb and ECMO in patients with severe pneumogenic sepsis. Thorac. Cardiovasc. Surg. 69, 246\u2013251. https:\/\/doi.org\/10.1055\/s-0040-1708479 (2021).","journal-title":"Thorac. Cardiovasc. Surg."},{"key":"49101_CR20","doi-asserted-by":"publisher","first-page":"1259384","DOI":"10.3389\/fped.2023.1259384","volume":"11","author":"G Bottari","year":"2023","unstructured":"Bottari, G. et al. Impact of CytoSorb and CKRT on hemodynamics in pediatric patients with septic shock: the PedCyto study. Front. Pediatr. 11, 1259384. https:\/\/doi.org\/10.3389\/fped.2023.1259384 (2023).","journal-title":"Front. Pediatr."},{"key":"49101_CR21","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1007\/s00134-018-5464-6","volume":"45","author":"EC Poli","year":"2019","unstructured":"Poli, E. C., Rimmel\u00e9, T. & Schneider, A. G. Hemoadsorption with CytoSorb\u00ae. Intensive Care Med. 45, 236\u2013239. https:\/\/doi.org\/10.1007\/s00134-018-5464-6 (2019).","journal-title":"Intensive Care Med."},{"key":"49101_CR22","doi-asserted-by":"publisher","first-page":"22","DOI":"10.5492\/wjccm.v10.i1.22","volume":"10","author":"R Paul","year":"2021","unstructured":"Paul, R. et al. Multicentered prospective investigator initiated study to evaluate the clinical outcomes with extracorporeal cytokine adsorption device (CytoSorb\u00ae) in patients with sepsis and septic shock. World J. Crit. care Med. 10, 22\u201334. https:\/\/doi.org\/10.5492\/wjccm.v10.i1.22 (2021).","journal-title":"World J. Crit. care Med."},{"key":"49101_CR23","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13054-023-04391-z","volume":"27","author":"A Jansen","year":"2023","unstructured":"Jansen, A. et al. CytoSorb hemoperfusion markedly attenuates circulating cytokine concentrations during systemic inflammation in humans in vivo. Crit. Care. 27, 117. https:\/\/doi.org\/10.1186\/s13054-023-04391-z (2023).","journal-title":"Crit. Care"},{"key":"49101_CR24","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1007\/s10753-016-0408-1","volume":"39","author":"T Eichhorn","year":"2016","unstructured":"Eichhorn, T. et al. Polystyrene-divinylbenzene-based adsorbents reduce endothelial activation and monocyte adhesion under septic conditions in a pore size-sependent manner. Inflammation 39, 1737\u20131746. https:\/\/doi.org\/10.1007\/s10753-016-0408-1 (2016).","journal-title":"Inflammation"},{"key":"49101_CR25","doi-asserted-by":"publisher","first-page":"e0191676","DOI":"10.1371\/journal.pone.0191676","volume":"13","author":"MC Gruda","year":"2018","unstructured":"Gruda, M. C. et al. Broad adsorption of sepsis-related PAMP and DAMP molecules, mycotoxins, and cytokines from whole blood using CytoSorb\u00ae sorbent porous polymer beads. PLoS ONE. 13, e0191676. https:\/\/doi.org\/10.1371\/journal.pone.0191676 (2018).","journal-title":"PLoS ONE"},{"key":"49101_CR26","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1093\/chromsci\/bmt155","volume":"52","author":"SC Cobzac","year":"2014","unstructured":"Cobzac, S. C., Casoni, D. & S\u00e2rbu, C. Lipophilicity of amine neurotransmitter precursors, metabolites and related drugs estimated on various TLC plates. J. Chromatogr. Sci. 52, 1095\u20131103. https:\/\/doi.org\/10.1093\/chromsci\/bmt155 (2014).","journal-title":"J. Chromatogr. Sci."},{"key":"49101_CR27","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1002\/jssc.201101032","volume":"35","author":"D Casoni","year":"2012","unstructured":"Casoni, D. & S\u00e2rbu, C. Comprehensive evaluation of lipophilicity of biogenic amines and related compounds using different chemically bonded phases and various descriptors. J. Sep. Sci. 35, 915\u2013921. https:\/\/doi.org\/10.1002\/jssc.201101032 (2012).","journal-title":"J. Sep. Sci."},{"key":"49101_CR28","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jpba.2019.02.035","volume":"170","author":"A Mirzahosseini","year":"2019","unstructured":"Mirzahosseini, A. et al. Characterization of the species-specific acid-base equilibria of adrenaline and noradrenaline. J. Pharm. Biomed. Anal. 170, 215\u2013219. https:\/\/doi.org\/10.1016\/j.jpba.2019.02.035 (2019).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"49101_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0165-0270(01)00502-7","volume":"113","author":"J Bergquist","year":"2002","unstructured":"Bergquist, J. et al. Catecholamines and methods for their identification and quantitation in biological tissues and fluids. J. Neurosci. Methods. 113, 1\u201313. https:\/\/doi.org\/10.1016\/S0165-0270(01)00502-7 (2002).","journal-title":"J. Neurosci. Methods"},{"key":"49101_CR30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1258\/000456304322664663","volume":"41","author":"RT Peaston","year":"2004","unstructured":"Peaston, R. T. & Weinkove, C. Measurement of catecholamines and their metabolites. Ann. Clin. Biochem. 41, 17\u201338. https:\/\/doi.org\/10.1258\/000456304322664663 (2004).","journal-title":"Ann. Clin. Biochem."},{"key":"49101_CR31","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3109\/00365518009092647","volume":"40","author":"J Pettersson","year":"1980","unstructured":"Pettersson, J., Hussi, E. & J\u00e4nne, J. Stability of human plasma catecholamines. Scand. J. Clin. Lab. Investig. 40, 297\u2013303. https:\/\/doi.org\/10.3109\/00365518009092647 (1980).","journal-title":"Scand. J. Clin. Lab. Investig."},{"key":"49101_CR32","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1515\/CCLM.2010.017","volume":"48","author":"NB Roberts","year":"2010","unstructured":"Roberts, N. B., Higgins, G. & Sargazi, M. A study on the stability of urinary free catecholamines and free methyl-derivatives at different pH, temperature and time of storage. Clin. Chem. Lab. Med. 48, 81\u201387. https:\/\/doi.org\/10.1515\/CCLM.2010.017 (2010).","journal-title":"Clin. Chem. Lab. Med."},{"key":"49101_CR33","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S0731-7085(99)00308-8","volume":"22","author":"EC Chan","year":"2000","unstructured":"Chan, E. C., Wee, P. Y. & Ho, P. C. Evaluation of degradation of urinary catecholamines and metanephrines and deconjugation of their sulfoconjugates using stability-indicating reversed-phase ion-pair HPLC with electrochemical detection. J. Pharm. Biomed. Anal. 22, 515\u2013526. https:\/\/doi.org\/10.1016\/S0731-7085(99)00308-8 (2000).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"49101_CR34","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1097\/00003246-199412000-00007","volume":"22","author":"C Klem","year":"1994","unstructured":"Klem, C. et al. Variability in dobutamine pharmacokinetics in unstable critically ill surgical patients. Crit. Care Med. 22, 1926\u20131932 (1994).","journal-title":"Crit. Care Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49101-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49101-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49101-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:26:24Z","timestamp":1781648784000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49101-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["49101"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-49101-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"assertion":[{"value":"8 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"GK received lecture honoraria from CytoSorbents Europe GmbH. SM received travel support and honoraria from CytoSorbents Europe GmbH for medical consultation. Apart from this, the authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted with approval by the Freiburg ethics commission international (before 2023; code 011\/1763) and the ethics commission of the Brandenburg State Medical Association (from 2023; code 2023-124-bio) and is in compliance with the principles of the Declaration of Helsinki. All subjects gave prior written informed consent for the scientific use of their blood.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"12897"}}